Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Molecules ; 25(23)2020 Nov 24.
Artigo em Inglês | MEDLINE | ID: mdl-33255372

RESUMO

Although a variety of beneficial health effects of natural flavonoids, including chrysin, has been suggested, poor solubility and bioavailability limit their practical use. As a promising delivery system, chrysin-loaded phytosomes (CPs) were prepared using egg phospholipid (EPL) at a 1:3 molar ratio and its antidiabetic effects were assessed in db/db diabetic mice. Male C57BLKS/J-db/db mice were fed a normal diet (control), chrysin diet (100 mg chrysin/kg), CP diet (100 mg chrysin equivalent/kg), metformin diet (200 mg/kg) or EPL diet (vehicle, the same amount of EPL used for CP preparation) for 9 weeks. Administration of CP significantly decreased fasting blood glucose and insulin levels in db/db mice compared with the control. An oral glucose tolerance test and homeostatic model assessment for insulin resistance were significantly improved in the CP group (p < 0.05). CP treatment suppressed gluconeogenesis via downregulation of phosphoenolpyruvate carboxykinase while it promoted glucose uptake in the skeletal muscle and liver of db/db mice (p < 0.05). The CP-mediated improved glucose utilization in the muscle was confirmed by upregulation of glucose transporter type 4, hexokinase2 and peroxisome proliferator-activated receptor γ during treatment (p < 0.05). The CP-induced promotion of GLUT4 plasma translocation was confirmed in the skeletal muscle of db/db mice (p < 0.05). Based on the results, CP showed greater antidiabetic performance compared to the control by ameliorating insulin resistance in db/db mice and phytosome can be used as an effective antidiabetic agent.


Assuntos
Portadores de Fármacos/química , Flavonoides/administração & dosagem , Resistência à Insulina , Compostos Fitoquímicos/química , Animais , Glicemia/efeitos dos fármacos , Diabetes Mellitus Experimental , Diabetes Mellitus Tipo 2 , Suplementos Nutricionais , Modelos Animais de Doenças , Flavonoides/química , Expressão Gênica , Gluconeogênese/efeitos dos fármacos , Glucose/metabolismo , Fígado/metabolismo , Masculino , Camundongos , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/metabolismo
2.
J Microbiol Biotechnol ; 29(1): 11-20, 2019 Jan 28.
Artigo em Inglês | MEDLINE | ID: mdl-30518021

RESUMO

Ecklonia cava, an edible marine brown alga (Laminariaceae), is a rich source of bioactive compounds such as fucoidan and phlorotannins. Ecklonia cava extract (ECE) was prepared using 70% ethanol extraction and ECE contained 67% and 10.6% of total phlorotannins and dieckol, respectively. ECE treatment significantly inhibited receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast differentiation of RAW 264.7 cells and pit formation in bone resorption assay (p <0.05). Moreover, it suppressed RANKL-induced NF-κB and mitogen-activated protein kinase signaling in a dose dependent manner. Downregulated osteoclast-specific gene (tartrate-resistant acid phosphatase, cathepsin K, and matrix metalloproteinase-9) expression and osteoclast proliferative transcriptional factors (nuclear factor of activated T cells-1 and c-fos) confirmed ECE-mediated suppression of osteoclastogenesis. ECE treatment (100 µg/ml) increased heme oxygenase-1 expression by 2.5-fold and decreased intercellular reactive oxygen species production during osteoclastogenesis. The effective inhibition of RANKL-stimulated osteoclast differentiation and oxidative stress by ECE suggest that ECE has therapeutic potential in alleviating osteoclast-associated disorders.


Assuntos
Benzofuranos/farmacologia , Heme Oxigenase-1/genética , Proteínas Quinases Ativadas por Mitógeno/metabolismo , NF-kappa B/metabolismo , Osteogênese/efeitos dos fármacos , Phaeophyceae/química , Ligante RANK/farmacologia , Animais , Reabsorção Óssea/genética , Proliferação de Células/efeitos dos fármacos , Proliferação de Células/genética , Regulação da Expressão Gênica/efeitos dos fármacos , Camundongos , Osteoclastos/citologia , Osteogênese/genética , Estresse Oxidativo/efeitos dos fármacos , Fosforilação/efeitos dos fármacos , Extratos Vegetais/química , Extratos Vegetais/farmacologia , Células RAW 264.7 , Espécies Reativas de Oxigênio/metabolismo , Transdução de Sinais/efeitos dos fármacos
3.
J Med Food ; 22(1): 74-80, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30489192

RESUMO

The effects of dietary supplementation with aqueous Hovenia dulcis Thunb. extract (HDE) (20 weeks) on high-fat diet (HFD)-induced nonalcoholic fatty liver disease and dyslipidemia were evaluated in mice. Supplementation with 200 and 800 mg/kg feed HDE (HDE200 and HDE800, respectively) resulted in no significant difference in growth in the HFD-fed groups. The triglyceride (TG) levels and free fatty acids were significantly decreased, whereas high-density lipoprotein cholesterol was increased in the HDE800 group (P < .05). The hepatic intracellular TGs were significantly decreased in the HDE-fed groups and lipogenic enzymes (acetyl CoA carboxylase, fatty acid synthase, stearoyl CoA desaturase, and diacylglycerol transferase) in the liver were significantly downregulated by HDE supplementation (P < .05). The diminished serum antioxidant enzyme activities in the HFD group were effectively restored by HDE supplementation, which also contributed to the attenuation of hyperlipidemia.


Assuntos
Dieta Hiperlipídica , Hipertrigliceridemia/prevenção & controle , Fígado/efeitos dos fármacos , Hepatopatia Gordurosa não Alcoólica/prevenção & controle , Fitoterapia , Rhamnaceae , Triglicerídeos/metabolismo , Acetil-CoA Carboxilase/metabolismo , Animais , HDL-Colesterol/sangue , Diacilglicerol O-Aciltransferase/metabolismo , Suplementos Nutricionais , Ácido Graxo Sintases/metabolismo , Ácidos Graxos não Esterificados/sangue , Hiperlipidemias , Hipertrigliceridemia/etiologia , Hipertrigliceridemia/metabolismo , Fígado/metabolismo , Masculino , Camundongos Endogâmicos C57BL , Hepatopatia Gordurosa não Alcoólica/metabolismo , Extratos Vegetais/farmacologia , Extratos Vegetais/uso terapêutico , Estearoil-CoA Dessaturase/metabolismo , Triglicerídeos/sangue
4.
Food Res Int ; 106: 149-155, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29579913

RESUMO

The absorption kinetics of food ingredients such as nanoemulsified vitamin E and green tea microstructures were evaluated by the intestinal in situ single perfusion technique. Absorption rate, sub-acute oral toxicity and organ morphology in a rat model were examined. The intestinal in situ single perfusion technique and HPLC analysis were applied to investigate the absorption rate of selected materials by examining time-dependent changes in the serum levels of catechin and dl-α-tocopherol. The acute toxicity test and histopathological evaluation were applied to analyze the safety of microsized green tea and nanosized vitamin E in a rat model. Total serum dl-α-tocopherol levels significantly increased with nanosized vitamin E administration (P<0.05). Rats treated to nanosized vitamin E until 90min after administration showed significantly increased absorption rate of serum dl-α-tocopherol levels at each time point (10min interval) (P<0.001). Rats administered 2000mg/kg of nanosized vitamin E and microsized green tea did not show signs of acute toxicity or death after 14days of observation. In addition, macroscopic analysis showed that there were no changes in representative organ sections of rats following the oral administration of food-related nanoscale materials. We successfully demonstrated that using nanosized vitamin E increased absorption rate to a greater extent than normal food-related material, and these results occurs via safety analyses on food-related nanoscale materials for human consumption. These results could be useful for the design and development of novel nanoemulsified vitamin E and microsized green tea formulations that can overcome the problem of their bioavailability and improve their efficacy while still maintaining their essential therapeutic efficacies.


Assuntos
Emulsões , Absorção Intestinal , Intestinos , Preparações de Plantas/farmacocinética , Chá/química , Vitamina E/farmacocinética , Vitaminas/farmacocinética , Animais , Disponibilidade Biológica , Catequina/administração & dosagem , Catequina/sangue , Catequina/farmacocinética , Cinética , Masculino , Nanoestruturas/efeitos adversos , Preparações de Plantas/administração & dosagem , Preparações de Plantas/sangue , Ratos Sprague-Dawley , Vitamina E/administração & dosagem , Vitamina E/sangue , Vitaminas/administração & dosagem , Vitaminas/sangue , alfa-Tocoferol/administração & dosagem , alfa-Tocoferol/sangue , alfa-Tocoferol/farmacocinética
5.
J Agric Food Chem ; 65(19): 3819-3826, 2017 May 17.
Artigo em Inglês | MEDLINE | ID: mdl-28474889

RESUMO

The effect of tricin, a methylated flavone widely distributed in cereals, on glucose uptake and the underlying molecular mechanism was investigated using C2C12 myotubes. Tricin significantly increased glucose uptake in C2C12 myotubes, regardless of the absence (1.4-fold at 20 µM) or presence (1.6-fold at 20 µM) of insulin. The GLUT4 expression on the plasma membrane was increased 1.6-fold after tricin treatment (20 µM) in the absence of insulin. Tricin treatment significantly activated the insulin-dependent cell signaling pathway, including the activation of insulin receptor substrate-1 (IRS1), phosphoinositide 3-kinase (PI3K), protein kinase B (AKT), and AKT substrate of 160 kDa (AS160). The oral administration of tricin (64 and 160 mg kg-1 of body weight day-1) also significantly lowered blood glucose levels in glucose-loaded C57BL/6 mice (p < 0.05). These results suggest that tricin has great potential to be used as a functional agent for glycemic control.


Assuntos
Grão Comestível/química , Flavonas/farmacologia , Flavonoides/farmacologia , Glucose/metabolismo , Fibras Musculares Esqueléticas/efeitos dos fármacos , Fibras Musculares Esqueléticas/metabolismo , Músculo Esquelético/metabolismo , Extratos Vegetais/farmacologia , Animais , Transporte Biológico/efeitos dos fármacos , Transportador de Glucose Tipo 4/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Músculo Esquelético/citologia , Músculo Esquelético/efeitos dos fármacos , Fosfatidilinositol 3-Quinases/metabolismo , Proteínas Proto-Oncogênicas c-akt/metabolismo , Transdução de Sinais/efeitos dos fármacos
6.
J Agric Food Chem ; 65(12): 2513-2520, 2017 Mar 29.
Artigo em Inglês | MEDLINE | ID: mdl-28279068

RESUMO

Arctigenin is a lignan abundant in Asteraceae plants and has anti-inflammatory, antiobesity, and anticancer activities. Obesity is one of the leading causes of several types of cancers including breast cancer. The current study was performed to investigate if arctigenin suppresses differentiation of preadipocytes and proliferation of breast cancer cells and to explore potential molecular mechanisms. Treatment of arctigenin reduced lipid accumulation in differentiated 3T3-L1 adipocytes in a dose- and time-dependent manner without toxicity. Arctigenin suppressed the expression of peroxisome proliferator-activated receptor-gamma (PPARγ), CCAAT/enhancer-binding protein-alpha (C/EBPα), perilipin, and fatty acid binding protein 4 (FABP4) in a dose-dependent manner in differentiated 3T3-L1 cells. Both total and unphosphorylated (active) ß-catenin were increased in whole cell lysates and the nuclear fraction of differentiated 3T3-L1 cells treated with 25 µM arctigenin. On the other hand, arctigenin decreased proliferation of two human breast cancer cells (MCF-7 and MDA-MB-231). Arctigenin induced apoptosis and decreased expression of total and unphosphorylated (active) ß-catenin and cyclin D1 in MCF-7, but not in MDA-MB-231. These data indicate that arctigenin suppressed adipogenesis in preadipocytes and activated apoptosis in estrogen receptor (ER) positive breast cancer cells through modulating expression of ß-catenin.


Assuntos
Adipócitos/efeitos dos fármacos , Adipogenia/efeitos dos fármacos , Antineoplásicos/farmacologia , Asteraceae/química , Neoplasias da Mama/metabolismo , Furanos/farmacologia , Lignanas/farmacologia , Extratos Vegetais/farmacologia , beta Catenina/metabolismo , Células 3T3-L1 , Adipócitos/citologia , Adipócitos/metabolismo , Animais , Apoptose/efeitos dos fármacos , Neoplasias da Mama/genética , Neoplasias da Mama/fisiopatologia , Proteína alfa Estimuladora de Ligação a CCAAT/genética , Proteína alfa Estimuladora de Ligação a CCAAT/metabolismo , Feminino , Humanos , Metabolismo dos Lipídeos/efeitos dos fármacos , Camundongos , PPAR gama/genética , PPAR gama/metabolismo , Transdução de Sinais/efeitos dos fármacos
7.
J Sci Food Agric ; 94(5): 850-6, 2014 Mar 30.
Artigo em Inglês | MEDLINE | ID: mdl-23893871

RESUMO

BACKGROUND: To improve the extraction and recovery of bioactive materials from cactus, the present study investigated the effect of polysaccharide-degrading enzymes [Rapidase-Viscozyme mixture, 1/3 (v/v)] treatment under high hydrostatic pressure (HHP). RESULTS: The dry weight of the extract increased with the use of increasing pressure regardless of enzyme treatment. However, the polyphenol content showed a tendency to decrease with the increase in pressure in the cactus extract with or without enzyme treatment. The enzyme-assisted extraction resulted in an increase of dry weight and polyphenol content in the cactus extract. The total sugar and reducing sugar contents of the cactus extract increased with increasing pressure in enzyme-assisted extraction. The uronic acid content of the cactus extract showed a pattern similar to that of the reducing sugars. The enzyme-assisted extraction also increased the contents of taxifolin, quercetin and isorhametin. The cactus extract obtained through enzyme-assisted extraction showed intense scavenging activity of both DPPH and ABTS radicals. The crude polysaccharides isolated from the extract (51.2% at 1000 µg mL⁻¹ for HHP extraction at 300 MPa) had higher anti-complementary activity than the others except for lipopolysaccharide (60.00% at 1000 µg mL⁻¹). HHP extraction and enzyme-assisted extraction using HHP showed an increase of anti-complementary activity compared with the heat and enzyme controls, respectively. CONCLUSION: Overall, the use of HHP in enzyme-assisted extraction resulted in more efficient extraction than the use of enzyme treatment alone.


Assuntos
Celulases/metabolismo , Sequestradores de Radicais Livres/isolamento & purificação , Fatores Imunológicos/isolamento & purificação , Opuntia/química , Extratos Vegetais/isolamento & purificação , Brotos de Planta/química , Poligalacturonase/metabolismo , Aspergillus/enzimologia , Ativação do Complemento/efeitos dos fármacos , Etnofarmacologia , Sequestradores de Radicais Livres/análise , Sequestradores de Radicais Livres/farmacologia , Proteínas Fúngicas/metabolismo , Hidrólise , Pressão Hidrostática , Fatores Imunológicos/análise , Fatores Imunológicos/farmacologia , Medicina Kampo , Complexos Multienzimáticos/metabolismo , Extratos Vegetais/química , Extratos Vegetais/farmacologia , Polissacarídeos/análise , Polissacarídeos/isolamento & purificação , Polissacarídeos/metabolismo , Polissacarídeos/farmacologia , Quercetina/análogos & derivados , Quercetina/análise , Quercetina/isolamento & purificação , Quercetina/farmacologia , República da Coreia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA